HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury.

Abstract
Since several different pathways are involved in cerebral ischemia/reperfusion injury, combination therapy rather than monotherapy may be required for efficient neuroprotection. In this study, we examined the protective effects of an apoptosis inhibitor Gly(14)-humanin (HNG) and a necroptosis inhibitor necrostatin-1 (Nec-1) on hypoxia/ischemia/reperfusion injury. Cultured mouse primary cortical neurons were incubated with Nec-1, HNG or both in a hypoxia chamber for 60 min. Cell viability was determined by MTS assay at 24h after oxygen-glucose deprivation (OGD) treatment. Mice underwent middle cerebral artery occlusion for 75 min followed by 24h reperfusion. Mice were administered HNG and/or Nec-1 (i.c.v.) at 4h after reperfusion. Neurological deficits were evaluated and the cerebral infarct volume was determined by TTC staining. Nec-1 or HNG alone had protective effects on OGD-induced cell death. Combined treatment with Nec-1 and HNG resulted in more neuroprotection than Nec-1 or HNG alone. Treatment with HNG or Nec-1 reduced cerebral infarct volume from 59.3 ± 2.6% to 47.0 ± 2.3% and 47.1 ± 1.5%, respectively. Combined treatment with HNG and Nec-1 improved neurological scores and decreased infarct volume to 38.6 ± 1.5%. In summary, we demonstrated that the combination treatment of HNG and Nec-1 conferred synergistic neuroprotection on hypoxia/ischemia/reperfusion injury in vitro and in vivo. These findings provide a novel therapeutic strategy for the treatment of stroke by combining anti-apoptosis and anti-necroptosis therapy.
AuthorsXingshun Xu, Kao-Wei Chua, Chu C Chua, Chun-Feng Liu, Ronald C Hamdy, Balvin H L Chua
JournalBrain research (Brain Res) Vol. 1355 Pg. 189-94 (Oct 08 2010) ISSN: 1872-6240 [Electronic] Netherlands
PMID20682300 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Imidazoles
  • Indoles
  • Intracellular Signaling Peptides and Proteins
  • Neuroprotective Agents
  • humanin
  • necrostatin-1
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Drug Synergism
  • Drug Therapy, Combination (methods)
  • Hypoxia-Ischemia, Brain (drug therapy, pathology, physiopathology)
  • Imidazoles (pharmacology, therapeutic use)
  • Indoles (pharmacology, therapeutic use)
  • Intracellular Signaling Peptides and Proteins (pharmacology, therapeutic use)
  • Mice
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Reperfusion Injury (drug therapy, pathology, physiopathology)
  • Signal Transduction (drug effects, physiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: